During the past decade, Northside Internal Medicine conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northside Internal Medicine" #1 sponsor was "AstraZeneca" with 3 trials, followed by "Bausch Health Americas, Inc." with 1 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Orexigen Therapeutics, Inc" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northside Internal Medicine" #1 collaborator was "Insulet Corporation" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Northside Internal Medicine" are "Diabetes Mellitus, Type 2" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "Cardiovascular Disease" (1 trials), "Cystitis, Interstitial" (1 trials) and "Diabetes Mellitus, Non-Insulin-Dependent" (1 trials). Many other conditions were trialed in "Northside Internal Medicine" in a lesser frequency.

Most popular intervention types in "Northside Internal Medicine" are "Drug" (8 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "AC2993" (3 trials), "Ancillary therapy" (1 trials), "Human regular U-500 insulin (CSII)" (1 trials) and "Human regular U-500 insulin (MDI)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northside Internal Medicine" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Northside Internal Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Northside Internal Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northside Internal Medicine, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".